Detalhe da pesquisa
1.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
N Engl J Med
; 386(19): 1793-1803, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544387
2.
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
Clin Gastroenterol Hepatol
; 21(1): 143-152.e3, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999207
3.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet
; 396(10246): 239-254, 2020 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711800
4.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
N Engl J Med
; 378(4): 354-369, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365309
5.
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(2): 468-476.e11, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376493
6.
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
J Viral Hepat
; 26(3): 337-349, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421537
7.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
N Engl J Med
; 373(27): 2599-607, 2015 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26571066
8.
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
N Engl J Med
; 373(8): 714-25, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26196502
9.
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
Gastroenterology
; 153(1): 113-122, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390869
10.
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry.
J Hepatol
; 62(5): 1040-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25450208
11.
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
JAMA
; 313(12): 1223-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25706092
12.
Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study.
Lancet HIV
; 11(3): e146-e155, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38307098
13.
A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
JHEP Rep
; 5(1): 100563, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644237
14.
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.
Lancet Gastroenterol Hepatol
; 7(7): 603-616, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325622
15.
Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients.
HIV Clin Trials
; 12(3): 131-40, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21684853
16.
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial.
Nat Med
; 27(7): 1262-1271, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239138
17.
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet HIV
; 8(7): e397-e407, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197772
18.
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial.
JAMA Netw Open
; 4(10): e2128652, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636914
19.
In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
Diagn Microbiol Infect Dis
; 61(3): 339-42, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18304772
20.
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
AIDS
; 21(6): F1-10, 2007 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-17413684